NCT02348372View on ClinicalTrials.gov

Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of GSK1278863A in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

34

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

June 3, 2011

Study Completion Date

June 3, 2011

Conditions

Anaemia

Interventions

DRUG

GSK1278863A Placebo

Matching size, shape and color

DRUG

GSK1278863A

A round, biconvex, white film coated tablet

Trial Locations (1)

2031

GSK Investigational Site, Randwick, Sydney

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT02348372 - Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of GSK1278863A in Healthy Subjects | Biotech Hunter | Biotech Hunter